Atrium Therapeutics, Inc.
RNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002093101
No open-market purchases or sales by Atrium Therapeutics, Inc. insiders were filed in the last 90 days; 154 institutions reported holding it in 13F filings for Q2 2026, worth $192.8M in total; no superinvestor holds it.
Members of Congress who traded RNA
No member of Congress has reported a trade in Atrium Therapeutics, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.